RecruitingNot ApplicableNCT07134192

Fluorescence-Guided Optimization of Sarcoma Margins


Sponsor

University of Aarhus

Enrollment

90 participants

Start Date

Sep 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This is a Danish national multicenter prospective cohort study to evaluate if fluorescence-guided surgery (FGS) using indocyanine green (ICG) can reduce the rate of positive margins following sarcoma resection.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Biopsy verified intermediate-to-high grade sarcoma of theextremity or trunk wall
  • Age\>18 years old
  • Tumor operable
  • Curative intent at time of surgery
  • Consent of patient

Exclusion Criteria5

  • History of allergic reaction to iodine-containing pharmaceuticals
  • End-stage renal disease or eGFR \<15
  • Patient decision
  • Lack of capacity
  • Inoperability

Interventions

PROCEDUREFluorescent-guided Surgery

Surgical treatment of the patient group will include the administration of a fluorescent dye and intraoperatively the resection will be aided and guided by the fluorescent signal. The wound bed will be inspected, areas with fluorescent signal will be excised and obtained separately for histopathology. Patients will receive the current post-operative standard of care for sarcoma patients


Locations(2)

Aarhus University Hospital

Aarhus N, Denmark

Rigshospitalet

Copenhagen, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07134192


Related Trials